ACHL
Companies
NASDAQ
Achilles Therapeutics plc - ADR
Health Care
$1.48
+$0.30 (+25.42%)
Price Chart
Overview
About ACHL
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
Market Cap
$38.5M
Volume
1.2M
Avg. Volume
1.9M
P/E Ratio
-0.7914439
Dividend Yield
0.00%
Employees
226.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.53
Low Correlation
Volatility
High (0.59)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ACHL shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025